Clinical Trials Browser

OTHER × Non-small Cell Lung Cancer Metastatic × Gefitinib × Clear all

NCT02299765 2017-11-27

Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC

Phase 4 Terminated

Non-small Cell Lung Cancer Metastatic